Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Ipsen patents

List of Ipsen patents

List of Vantrix patents

List of RPB Safety LLC patents

List of Verimatrix patents

Founders educated at University of Salamanca

List of AI computing performance companies

Patents where

Current Assignee

Name

is

Ipsen

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11434265 Chimeric neurotoxins	Patent 11434265 was granted and assigned to Ipsen on September, 2022 by the United States Patent and Trademark Office.	Ipsen	Ipsen		United States Patent and Trademark Office	11434265	September 6, 2022
	‌ US Patent 11534394 Pharmaceutical composition containing botulinum neurotoxin	Patent 11534394 was granted and assigned to Ipsen on December, 2022 by the United States Patent and Trademark Office.	Ipsen	Ipsen		United States Patent and Trademark Office	11534394	December 27, 2022
	‌ US Patent 11634460 Non-neuronal snare-cleaving botulinum neurotoxins	Patent 11634460 was granted and assigned to Ipsen on April, 2023 by the United States Patent and Trademark Office.	Ipsen	Ipsen		United States Patent and Trademark Office	11634460	April 25, 2023
	‌ US Patent 7638546 Imidazolyl derivatives	Patent 7638546 was granted and assigned to Ipsen on December, 2009 by the United States Patent and Trademark Office.		Ipsen		United States Patent and Trademark Office	7638546	December 29, 2009
	‌ US Patent 7517853 Somatostatin-dopamine chimeric analogs	Patent 7517853 was granted and assigned to Ipsen on April, 2009 by the United States Patent and Trademark Office.		Ipsen		United States Patent and Trademark Office	7517853	April 14, 2009
	‌ US Patent 8236759 GLP-1 pharmaceutical compositions	Patent 8236759 was granted and assigned to Ipsen on August, 2012 by the United States Patent and Trademark Office.		Ipsen		United States Patent and Trademark Office	8236759	August 7, 2012
	‌ US Patent 8227485 Benzimidazole and imidazopyridine derivatives and use thereof as a medicament	Patent 8227485 was granted and assigned to Ipsen on July, 2012 by the United States Patent and Trademark Office.		Ipsen		United States Patent and Trademark Office	8227485	July 24, 2012
	‌ US Patent 8188133 Imidazole derivatives, preparation and user thereof as medicine	Patent 8188133 was granted and assigned to Ipsen on May, 2012 by the United States Patent and Trademark Office.		Ipsen		United States Patent and Trademark Office	8188133	May 29, 2012
	‌ US Patent 7795284 4,7-dioxobenzothiazole-2-carboxamide derivatives, their preparation and their therapeutic uses	Patent 7795284 was granted and assigned to Ipsen on September, 2010 by the United States Patent and Trademark Office.		Ipsen		United States Patent and Trademark Office	7795284	September 14, 2010
	‌ US Patent 7662784 Method for decreasing body weight using a somatostatin receptor agonist	Patent 7662784 was granted and assigned to Ipsen on February, 2010 by the United States Patent and Trademark Office.		Ipsen		United States Patent and Trademark Office	7662784	February 16, 2010
	‌ US Patent 7790680 Stable pharmaceutical composition containing factor VIII	Patent 7790680 was granted and assigned to Ipsen on September, 2010 by the United States Patent and Trademark Office.		Ipsen		United States Patent and Trademark Office	7790680	September 7, 2010
	‌ US Patent 7932231 Compositions and methods for stimulating gastrointestinal motility	Patent 7932231 was granted and assigned to Ipsen on April, 2011 by the United States Patent and Trademark Office.		Ipsen		United States Patent and Trademark Office	7932231	April 26, 2011
	‌ US Patent 7754253 Botulinum toxin for the treatment of reduction of hair growth	Patent 7754253 was granted and assigned to Ipsen on July, 2010 by the United States Patent and Trademark Office.		Ipsen		United States Patent and Trademark Office	7754253	July 13, 2010
	‌ US Patent 8759299 Analogues of insulin-like growth factor-1 (IGF-1) having amino acid substitution at position 59	Patent 8759299 was granted and assigned to Ipsen on June, 2014 by the United States Patent and Trademark Office.		Ipsen		United States Patent and Trademark Office	8759299	June 24, 2014
	‌ US Patent 8288395 Pyrimido-benzimidzole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors	Patent 8288395 was granted and assigned to Ipsen on October, 2012 by the United States Patent and Trademark Office.		Ipsen		United States Patent and Trademark Office	8288395	October 16, 2012
	‌ US Patent 7005420 Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides	Patent 7005420 was granted and assigned to Ipsen on February, 2006 by the United States Patent and Trademark Office.		Ipsen		United States Patent and Trademark Office	7005420	February 28, 2006
	‌ US Patent 7026431 Sustained release ionic conjugate	Patent 7026431 was granted and assigned to Ipsen on April, 2006 by the United States Patent and Trademark Office.		Ipsen		United States Patent and Trademark Office	7026431	April 11, 2006
	‌ US Patent 6911218 Sustained release ionic conjugate	Patent 6911218 was granted and assigned to Ipsen on June, 2005 by the United States Patent and Trademark Office.		Ipsen		United States Patent and Trademark Office	6911218	June 28, 2005
	‌ US Patent 6893645 Process to make a sustained release formulation	Patent 6893645 was granted and assigned to Ipsen on May, 2005 by the United States Patent and Trademark Office.		Ipsen		United States Patent and Trademark Office	6893645	May 17, 2005

19 results

0 selected

19 results

0 selected